NCT03838627View on ClinicalTrials.gov

Feasibility and Agreement of Remote Evaluation of Resting Heart Rate and Heart Rate Variability in Survivors of Hodgkin Lymphoma Treated With Chest Radiation (PILOT STUDY-SURVIVOR)

CompletedOBSERVATIONAL
Enrollment

34

Participants

Timeline

Start Date

February 5, 2019

Primary Completion Date

January 19, 2021

Study Completion Date

June 30, 2023

Conditions
Hodgkin Disease
Trial Locations (1)

38105

Kirsten Ness, Memphis

All Listed Sponsors
lead

St. Jude Children's Research Hospital

OTHER

NCT03838627 - Feasibility and Agreement of Remote Evaluation of Resting Heart Rate and Heart Rate Variability in Survivors of Hodgkin Lymphoma Treated With Chest Radiation (PILOT STUDY-SURVIVOR) | Biotech Hunter | Biotech Hunter